Standout Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis 2023 2026 2024145
  1. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis (2023)
    Geert D’Haens, Marla C. Dubinsky et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation
2024 Standout
9 intermediate papers

Works of Stefanie Howaldt being referenced

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Recombinant Erythropoietin for the Treatment of Anemia in Inflammatory Bowel Disease
1996
and 2 more

Author Peers

Author Last Decade Papers Cites
Stefanie Howaldt 338 247 521 333 31 1.2k
Michael J. Burt 405 500 300 249 27 1.3k
Palle Bager 512 395 315 145 45 1.2k
Judith A Collett 389 405 194 157 21 1.1k
E Signer 122 118 426 101 50 1.0k
I. W. Delamore 132 124 306 133 68 1.2k
H. O. Nieweg 82 236 208 128 73 1.3k
D. O’B. Hourihane 102 161 268 138 38 1.4k
Jeffrey S. Jhang 67 149 208 125 33 1.1k
Sheila Worlledge 212 145 531 180 31 1.1k
John H. Githens 99 132 417 266 48 1.0k

All Works

Loading papers...

Rankless by CCL
2026